JPRN-UMIN000022362招募中2 期
A Phase II, Open-label, Multicenter, Translational Study for Biomarkers of Eribulin Mesylate: Evaluation of the Utility of Monitoring Epithelial-to-Mesenchymal Transition (EMT) Markers on Tumor Cells in the Malignant Plural Effusion of Patients with Metastatic Breast Cancer - EXPECT-study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of eribulin therapy 2) Pregnant, lactating or woman not agree with contraception within the study period 3) CNS metastasis with symptom or require treatment 4) Active infection excluding well-controlled chronic hepatitis B infection
研究者
相似试验
终止
不适用
Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases (LM) Associated With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung CancerKCT0005540Samsung Medical Center80
进行中（未招募）
1 期
Proof-of-concept study for SAR445088 in chronic inflammatory demyelinating polyneuropathy (CIDP)Chronic inflammatory demyelinating polyneuropathyMedDRA version: 21.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2020-004006-54-NLSanofi-Aventis Recherche & Développement158
招募中
2 期
A Phase 2, multicenter, open-label, non-randomized, proof-of-concept study evaluating the efficacy, safety, and tolerability of SAR445088 (previously BIVV020) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)nerve disorder10012303Chronic inflammatory demyelinating polyneuropathyNL-OMON54382Sanofi B.V.6
进行中（未招募）
1 期
Proof-of-concept study for SAR445088 in chronic inflammatory demyelinating polyneuropathy (CIDP)Chronic inflammatory demyelinating polyradiculoneuropathyMedDRA version: 21.1Level: PTClassification code: 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathy Class: 100000004852CTIS2024-512345-16-00Sanofi-Aventis Recherche & Developpement98
招募中
2 期
Proof-of-concept study for SAR445088 in chronic inflammatory demyelinating polyneuropathy (CIDP)2024-512345-16-00Sanofi-Aventis Recherche & Developpement56